After treating cardiac tamponade arising from atrial fibrillation (Afib) catheter ablation, pericardial drains do not need to be kept in place for an additional 12 to 24 hours, researchers suggested.
TURIN, ITALY (updated) — The European Society of Cardiology (ESC) Working Group on Myocardial and Pericardial Diseases has developed a stepwise scoring system to identify patients who need immediate ...
An IRB-approved retrospective review of the medical records of 409 consecutive HSCT recipients, who underwent transplant between January 2012 and April 2016 at Cincinnati Children’s Hospital Medical ...
Open-label study of pemetrexed alone for chemonaive patients and pre-treated patients with malignant pleural mesothelioma: Outcomes of the International Expanded Access Program (EAP) ...
Long-Term Follow-Up of a Large Cohort of Patients with Intermediate Lesions Assessed with IVUS. Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ...
Cardiac tamponade is excessive collection of fluid in the pericardial sac surrounding the heart that leads to restriction of cardiac function and causes critical cardiogenic shock and rapid ...
BARCELONA, SPAIN — In the Post-Operative Pericardial Effusion-2 (POPE-2) trial, once again, the anti-inflammatory drug colchicine was not effective for warding off complications following cardiac ...
IRVINE, Calif.--(BUSINESS WIRE)--ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results presented at the 2020 Virtual Program of the ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A 44-year-old ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Allogeneic hematopoietic SCT (HSCT) is the only curative treatment for many malignant and non-malignant diseases. As survival improves, the frequency of late effects, among which chronic GVHD (cGVHD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results